Obesity and heart

Česká verzia

Authors: Štěpán Svačina
Authors place of work: III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Published in the journal: Vnitř Lék 2014; 60(12): 1068-1071
Category: 70. birthday prof. MUDr. Michael Aschermann, DrSc., FESC, FACC

Summary

Cardiovascular complications of obesity are traditionally considered an important complication of obesity. Obesity itself is probably not direct cause of atherosclerosis or coronary heart disease. This may occur indirectly in metabolic complications of obesity, especially diabetes and metabolic syndrome. However, thrombogenicity potential of obesity contributes to embolism and atherosclerosis development. In cardiology is well-known a phenomenon of obesity paradox when obese patients have better prognosis than thin. This is the case of heart failure and some other cardiovascular diseases. Recently, a new concept has emerged of myokines – hormones from muscle tissue that have extensive protective effects on organism and probably on heart. Whether heart is a source of myokines is uncertain. However, undoubted importance has epicardial and pericardial fatty tissue. The epicardial fatty tissue has mainly protective effects on myocardium. This fatty tissue may produce factors of inflammation affecting the myocardium. Relationship between amount of epicardial fatty tissue and coronary heart disease is rather pathogenic. Currently, it is certain that obesity brings more metabolic and cancer complications than cardiovascular and accurate contribution to pathogenic or protective character of fatty tissue in cardiology requires further research. Nevertheless, the conclusion is that adipose tissue of organism and around the heart may be in some circumstances beneficial.

Key words:
adipokines – complications of obesity – epicaridal fatty tissue – myokines – obesity paradox – pericardial fatty tissue

Zdroje

1. Ardestani A, Hoffman HJ, Cooper HA. Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 2010; 106(3): 369–373.

2. Artham SM, Lavie CJ, Milani RV et al. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J 2009; 9(3):124–132.

3. Cherian S, Lopaschuk GD, Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab 2012; 303(8): E937-E949.

4. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683–689.

5. Jee SH, Sull JW, Park J et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355(8): 779–787.

6. Kim TH, Park J, Park JK et al. Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: An analysis of over 600-patients. Int J Cardiol 2014; 176(3): 841–846.

7. Lainscak M, von Haehling S, Doehner W et al. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012; 3(1): 1–4.

8. Mahabadi AA, Lehmann N, Kälsch H et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 2014; 7(9): 909–916.

9. Pedersen BK. Muscle as a secretory organ. Compr Physiol 2013; 3(3): 1337–1362.

10. Reis JP, Allen N, Gibbs BB et al. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: The CARDIA Study. Obesity (Silver Spring) 2014; 22(11):2434–2440.

11. Roberts LD, Boström P, O’Sullivan JF et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab 2014; 19(1): 96–108.

12. Shaw KA, Edelman AB. Obesity and oral contraceptives. Best Pract Res Clin Endocrinol Metab 2013; 27(1): 55–65.

13. Svačina Š. Obezitologie a teorie metabolického syndromu. Triton: Praha 2013. ISBN 978–80–7387–678–4.

14. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009; 73(1): 13–18.

15. Yamada H, Sata M. The role of pericardial fat: The good, the bad and the ugly. J Cardiol 2014; pii S0914–5087(14)00203–2. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jjcc.2014.07.004>.